Yes.
Optometrists can prescribe medication in every state — the Bureau of Labor Statistics puts it that plainly — but the drug list is the state's, not the profession's.
Which topical drops, which oral drugs and which controlled substances are written into the state optometry act you are licensed under; the federal DEA layer sits on top of it.
This page reads that authority as the job question it is.
Can optometrists prescribe medication?
The Bureau of Labor Statistics (BLS) states it flatly: all states allow optometrists to prescribe medication.
The same sentence carries the catch — states vary in the type of medication they allow optometrists to prescribe.
Prescribing medication, as permitted by state law, sits on BLS's list of typical optometrist duties, alongside diagnosing refractive errors and eye diseases such as glaucoma and providing pre- and post-operative care.
The duty is national; its boundaries are not.
States also vary on whether optometrists may perform surgery or other procedures, such as providing vaccinations — a separate question this page stays off.
What varies in practice is the tier of license behind the pad.
A state's optometry act can be written in layers — a base license, therapeutic authority for drug treatment, and, where the tiers go further, certificates that unlock oral medication or glaucoma care.
Employers name the layer directly: U.S. Air Force optometrists, for one, must hold an unrestricted state license to practice optometry using therapeutic pharmaceutical agents (TPAs), per the service's October 2026 requirements page.
For the whole duty list and the exam-room workflow around it, see what optometrists do.
The rest of this page unpacks the pad itself: drug classes first, then controlled substances and DEA, then the state-by-state picture.
What drugs can ODs prescribe (topical, oral)?
Topical medication is the core of therapeutic authority.
In Texas, the therapeutic optometrist tier (Occupations Code 351.358) is the one that may prescribe — the state's base "optometrist" tier may not treat eye disease or prescribe drugs at all.
Oral medication is where the tiers matter.
In Texas, a therapeutic optometrist may not prescribe oral or parenteral medication, or treat glaucoma, without a board certificate as an "optometric glaucoma specialist" — earned through an instructional clinical review course and a board-approved exam (Occupations Code § 351.3581).
Maine folds the top level into its entry license instead: new optometrists there are issued only the "therapeutic advanced glaucoma" license level, which covers prescribing for ocular conditions including glaucoma and Schedule III-V drugs (32 M.R.S. §19304).
The oral list is still moving.
Per the American Optometric Association, Minnesota's 2025 law (HF 2) added oral steroids up to 14 days to the state's optometric scope.
For the drug-class questions people type — antibiotics, drops for eye infections — the answer follows the same rule: the state's act names the categories, and a state can scope a class by condition.
Utah limits oral antibiotics to eyelid-related and rule-specified conditions, and allows hydrocodone combination drugs or Schedule III substances only for eye or adnexa pain, up to a 72-hour quantity with no refills.
The full drug-by-drug, state-by-state comparison — injections and lasers included — lives on our optometry scope of practice by state page.
This page stays on prescribing.
Controlled substances and DEA registration
Controlled-substance authority is written state by state, so read the schedules the way each statute writes them.
Texas caps therapeutic optometrists at no more than one 3-day supply of a Schedule III, IV or V controlled substance, and the statute grants no Schedule II authority (Occupations Code 351.358(c)).
Alabama bars Schedule I and II narcotic analgesics and any Schedule III product containing hydrocodone, and limits other Schedule III prescriptions to 96 hours (Alabama Code 34-22-1).
California's TPA-certified optometrists may prescribe, among controlled substances, only codeine with compounds, hydrocodone with compounds and tramadol — limited to three days, with ophthalmologist referral if pain persists (BPC 3041(a)(5)(B)).
Colorado authorizes Schedule III-V drugs for ocular disease and, of Schedule II, only hydrocodone combination drugs, while excluding posterior uveitis treatment and intraocular injections (Colorado Revised Statutes 12-275-103).
Alaska lets optometrists prescribe controlled substances under board standards and caps an initial outpatient opioid prescription at a 4-day supply for adults, with documented exceptions.
Maine's therapeutic advanced glaucoma level reaches Schedule III-V, but not Schedule I-II drugs, and not drugs given only by subcutaneous, intramuscular, intravenous or retrobulbar injection (anaphylaxis excepted).
The federal layer sits on top of the state layer.
An optometrist who prescribes controlled substances registers with the Drug Enforcement Administration, under the state authority they hold.
DEA's practitioner pages sort non-physician prescribers into "mid-level practitioners" — individual practitioners other than a physician, dentist, veterinarian or podiatrist permitted by their jurisdiction to dispense controlled substances.
The definition page does not name optometrists explicitly, and DEA's mid-level-practitioner-by-state table is marked "Under Construction."
The schedules an OD can register for come from state law, not from a DEA list.
Registration is a line item: DEA practitioner registration (dispensing or instructing, Schedules II-V; Form 224 new, 224a renewal) costs $888 for a 3-year registration under 21 CFR 1301.13(e).
After the first registration period, it expires 36 months from the initial expiration date.
One more state layer: DEA also splits the states by whether a practitioner needs a second, state controlled-substance registration before applying.
DEA's list of second-license states includes Alabama, Connecticut, Illinois, Michigan and Utah, among others; its counterpart list of states where the professional license alone suffices includes California, Colorado, Maine and Texas.
Both tables describe practitioners generally, not optometrists specifically — confirm with the state controlled-substance agency where you practice.
How state law varies
States write prescribing authority in structurally different ways, not just in list length.
Alabama runs a two-tier system: use of therapeutic drugs is limited to optometrists the board approves, and applicants submit a board pharmaceutical-agent protocol after passing the standard exam.
Texas names its tiers — "optometrist," then "therapeutic optometrist," then the optometric glaucoma specialist certificate for oral, parenteral and glaucoma care.
California splits the authority into certifications — TPA (therapeutic agents), TPL (lacrimal) and TPG/TLG (glaucoma), each carrying its own designation fee.
Maine went the other direction: new optometrists are issued only the therapeutic advanced glaucoma level, with no lower drug tier for new licensees.
The career consequence is easy to state and easy to miss: the same job title sits on a different pad in Austin, Birmingham, Sacramento and Portland, Maine.
A posting that says "full scope" is talking about the state's scope, so read the duties against the state optometry act — and against the tier your license actually carries — rather than against a national template.
The optometrist career guide carries the licensing path behind those tiers — degree, NBEO exams, state law exams and license types — and the scope-by-state page linked above holds the full drug, injection and laser comparison.
Prescribing rules move
What this means for your daily practice
Before you sign anything in a new state, read the drug authority the way the board writes it.
The base license can exclude drug treatment entirely, as Texas's base tier does, or condition therapeutic drugs on board approval plus a protocol, as Alabama's does.
Check the tier your license will carry and what the next tier adds.
Oral medication and glaucoma care sit behind a course-plus-exam certificate in Texas and behind California's designation system; in Maine, the entry license already reaches Schedule III-V.
If the role includes pain management or any controlled-substance work, read the schedule list, the quantity cap and the refill rule together.
The caps differ sharply: Texas's 3-day supply, California's three-day limit on its three named drugs, Alabama's 96-hour Schedule III ceiling, Utah's 72-hour no-refill rule.
Then check whether the state adds a second registration to the DEA's.
Budget for the federal paperwork if you will prescribe controlled substances: $888 per DEA practitioner registration (dispensing or instructing), on a 36-month cycle.
And read employer requirements literally: a posting that demands an unrestricted license using therapeutic pharmaceutical agents is naming the tier, not decorating the ad.
Career information, not medical, licensing, billing or legal advice. Prescribing authority is set by each state's optometry statute and board — confirm the current rules with the state board of optometry where you practice, and with DEA for registration questions.

